| NCT05061771 | Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) | WITHDRAWN | PHASE3 | 2022-05-06 | 2022-08-01 | 2022-08-01 |
| NCT04784455 | Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy | TERMINATED | PHASE3 | 2021-02-01 | 2024-05-15 | 2024-05-15 |
| NCT04037891 | Topical rVA576 for Treatment of Atopic Keratoconjunctivitis | TERMINATED | PHASE1, PHASE2 | 2019-03-04 | 2020-04-30 | 2020-04-30 |
| NCT04035733 | rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects | COMPLETED | PHASE2 | 2018-09-25 | 2020-04-29 | 2020-03-12 |
| NCT03588026 | Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576 | COMPLETED | PHASE3 | 2018-06-07 | 2020-09-03 | 2020-09-03 |
| NCT03427060 | Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms | COMPLETED | PHASE2 | 2018-05-14 | 2021-02-03 | 2018-11-15 |
| NCT03829449 | rVA576 (Coversin) Long Term Safety and Efficacy Surveillance Study | TERMINATED | PHASE3 | 2017-03-13 | 2020-08-29 | 2020-08-29 |
| NCT02591862 | Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) | COMPLETED | PHASE2 | 2016-02 | 2018-03-20 | 2018-03-20 |
| NCT02031445 | Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% | TERMINATED | PHASE2 | 2014-08 | 2015-03 | 2015-03 |